Physician profile
William S Arnold
NPI 1295734820
$2,480.31
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $320 · 2020: $340 · 2021: $744 · 2022: $606 · 2023: $451 · 2024: $19.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $471.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $471.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $741.57 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $277.74 | 2019-2022 | |
| Amgen INC. | $196.10 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $190.14 | 2021-2023 | Jardiance |
| Esperion Therapeutics, INC. | $188.27 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $159.44 | 2021-2023 | Verquvo |
| Pfizer INC. | $142.53 | 2021-2023 | |
| E.R. Squibb & Sons, L.L.C. | $142.25 | 2019-2023 | Camzyos |
| Boston Scientific Corporation | $133.04 | 2020-2023 | Watchman Access System |
| Astrazeneca Pharmaceuticals Lp | $126.35 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $91.48 | 2019 | |
| Abbott Laboratories | $23.00 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.67 | 2021 | |
| Arbor Pharmaceuticals, INC. | $15.86 | 2020 | |
| Edwards Lifesciences Corporation | $14.30 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $11.63 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $7.94 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Arnold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.